View Single Post
Old 07-17-2017, 01:13 AM   #1
News
Senior Member
 
News's Avatar
 
Join Date: Oct 2007
Posts: 18,945
Side effects not a major problem for new class of breast cancer drugs

A ground-breaking new class of oral drugs for treating breast cancer, known as cyclin-dependent kinase (CDK) inhibitors, are generally well-tolerated, with a manageable toxicity profile for most...

More...
News is offline   Reply With Quote